Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Prosthetic valve endocarditis]

B Almirante Gragera1, M P Tornos Mas, J Soler-Soler

  • 1Servicio de Enfermedades Infecciosas, Hospital General Vall d'Hebron, Barcelona. almiran@hg.vhebron.es

Revista Espanola De Cardiologia
|July 11, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enoxaparin as bridging anticoagulant treatment in cardiac surgery.

Heart (British Cardiac Society)·2007
Same author

Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart.

Heart (British Cardiac Society)·2006
Same author

Thirty day prognosis of patients with acute pulmonary oedema complicating acute coronary syndromes.

Heart (British Cardiac Society)·2005
Same author

[Empiric treatment of community-acquired pneumonia].

Revista clinica espanola·2004
Same author

Usefulness of myocardial perfusion SPECT in patients with left bundle branch block and previous myocardial infarction.

Heart (British Cardiac Society)·2003
Same author

Experience with enoxaparin in patients with mechanical heart valves who must withhold acenocumarol.

Heart (British Cardiac Society)·2003
Same journal

[Early remote monitoring of pacemaker devices and benefits of this paradigm shift. The FAST REMOTE study].

Revista espanola de cardiologia·2023
Same journal

[Cardiopulmonary exercise test in patients with post SARS-CoV-2 sequelae: need to create a multicenter working group. Response].

Revista espanola de cardiologia·2023
Same journal

[Myocarditis related SARS-CoV-2 infection or vaccination: an expert consensus statement on its diagnosis and management].

Revista espanola de cardiologia·2023
Same journal

[Cardiopulmonary exercise test in patients with post SARS-CoV-2 sequelae: need to create a multicenter working group].

Revista espanola de cardiologia·2023
Same journal

[Environment and cardiovascular health: causes, consequences and opportunities in prevention and treatment].

Revista espanola de cardiologia·2022
Same journal

[Third-degree atrioventricular block associated with the SARS-CoV-2 mRNA vaccine].

Revista espanola de cardiologia·2022
See all related articles

Prosthetic valve endocarditis affects 4% of patients, with early cases linked to staphylococci and prosthetic malfunction. Despite treatment, mortality for prosthetic valve endocarditis remains high, particularly in early infections.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Cardiac Surgery

Background:

  • Infective endocarditis (IE) is a serious complication affecting prosthetic heart valves.
  • Approximately 4% of individuals with prosthetic valves develop IE.
  • The condition involves infection of the heart's inner lining and circulating microorganisms.

Purpose of the Study:

  • To review the characteristics and outcomes of infective endocarditis in prosthetic valve carriers.
  • To differentiate between early and late prosthetic valve endocarditis.
  • To highlight the challenges in managing this condition.

Main Methods:

  • Literature review of prosthetic valve endocarditis.
  • Analysis of etiological factors in early and late cases.

Related Experiment Videos

  • Comparison of clinical manifestations and treatment outcomes.

    • Main Results:

    • Early prosthetic endocarditis (within 12 months) is primarily caused by staphylococci.
    • Late prosthetic endocarditis shares etiological similarities with native valve endocarditis.
    • Clinical presentation varies, involving bacteremia and prosthetic malfunction in early cases, and resembling native valve disease in late cases.

    Conclusions:

    • Prosthetic valve endocarditis presents distinct challenges compared to native valve endocarditis.
    • Mortality rates remain high, especially for early prosthetic valve endocarditis, despite combined medical and surgical interventions.
    • Further research into optimized treatment strategies is warranted.